期刊档案 · Health Professions-Pharmacy
Journal of Advanced Pharmacy Education and Research
ISSN 2249-3379 · Society of Pharmaceutical Education & Research [SPER]
Journal of Advanced Pharmacy Education and Research 订阅期刊，收取 APC，金额未公布，2025 年发文 95 篇，Scopus 收录。
研究范围
研究范围与定位
Journal of Advanced Pharmacy Education and Research 由 Society of Pharmaceutical Education & Research [SPER] 出版。按 OpenAlex 近年发文统计，该刊主要发表 Pharmacy and Medical Practices、Innovations in Medical Education、Medicinal Plant Research 等主题的论文，这 3 个主题约占 34%，主导子领域为 Pharmaceutical Science。（根据 OpenAlex 主题统计与中科院分区数据生成）
It is a journal aiming to communicate high quality original research work, reviews, short communications, case report, also Letter to editor that contribute significantly to further the scientific knowledge related to the field of pharmaceutical sciences.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Health Professions-Pharmacy
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics14%
- Innovations in Medical EducationMedicine10%
- Medicinal Plant ResearchAgricultural and Biological Sciences10%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics7%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.1%
- Pharmaceutical Practices and Patient OutcomesMedicine4.6%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences4%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics4%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
CiteScore 分区（Scopus，2026 年 6 月版）
| 学科 | 分区 | 排名 | 百分位 |
|---|---|---|---|
| Pharmacy | Q1 | 12/52 | 77% |
| Education | Q2 | 633/1698 | 62% |
| Pharmaceutical Science | Q3 | 97/191 | 49% |
Scopus 按 CiteScore 在每个学科内为期刊排名，百分位 75 及以上为 Q1，每 25 为一档；与中科院分区是不同体系。LetPub
数据库收录
ScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
CAB Abstracts出版商官网
其他：EBSCO、Index Copernicus、OpenJGate、Scimago Journal Ranking、Ulrich's International Periodical Directory、ABCD index
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- CiteScore 2026-06
- 3LetPub ·
- SJR 2026-06
- 0.33LetPub ·
- SNIP 2026-06
- 0.4LetPub ·
- h-index
- 16OpenAlex ·
- i10-index
- 52OpenAlex ·
- 两年平均被引
- 1.55OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 533 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 67 | 67 | 360 |
| 2025 | 95 | 95 | 510 |
| 2024 | 73 | 72 | 385 |
| 2023 | 88 | 88 | 420 |
| 2022 | 70 | 31 | 213 |
| 2021 | 110 | 32 | 59 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊LetPub
订阅期刊，文章需订阅或购买阅读，通常不收取版面费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| 出版商官网 | 有，金额未公布 | — | — |
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点6 项，摘自作者指南
- 摘要
- 150–250 词
- 关键词
- ≥ 4 个
- 正文篇幅
- ≤ 7,000 词
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 首次投稿格式
- 允许不按期刊格式排版（free format）
- 投稿信（Cover letter）
- 可选
接收的文章类型7 种，含篇幅限制
- case studyds, and statistical analyses used. Like case studies, cross-sectional study submissions are limited to 3,000 words, with up to 50 references to ensure thorough …正文 ≤ 3,000 词
- letterwithin 6 months of article publication. Letters should have a maximum of 1,500 words. Original Articles The research Articles report on primary正文 ≤ 1,500 词
- letter to editorLetter to Editor未说明篇幅
- letter to the editorA letter to the Editor is a brief report that is within the journal's scope and of particular interest to the community, but not suitable as a standard research…正文 ≤ 1,500 词
- original articleThe research Articles report on primary research. They must describe significant and original observations. Consideration for publication is based on the articl…正文 ≤ 5,000 词 · 参考文献 ≤ 50
- review articleReview Articles are considered reviews of research or summary articles. They are state-of-the-art papers covering a current topic by experts in the field. They …正文 ≤ 7,000 词 · 参考文献 ≤ 100
- short communicationsShort Communications未说明篇幅
官网政策摘录作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、查重、试验注册 / 报告规范
- 作者资格 Credit of the authorship should be based on
Consequential inputs to the concept and design, procurement of data or analysis, and interpretation of data.
原文 ↗出版商官网 ·- 利益冲突 Conflict of interest
Manuscripts must include conflict of interest and funding statements before the reference list. 模型摘要
Any interest, financial relationship, personal relationship, religious or political beliefs that might influence the objectivity of the author can be considered as a potential source of conflict of interest. All manuscripts submitted to the journal must include a conflict of the interest disclosure statement or a declaration by the authors that they do not have any conflicts of interest to declare…
原文 ↗出版商官网 ·- 出版伦理
Human and animal studies require ethics committee approval with reference number. 模型摘要
Studies involving humans and animals must have been performed with the approval of an appropriate ethics committee and provide the reference number.
原文 ↗出版商官网 ·- 许可与版权
Authors transfer copyright to the publisher upon acceptance. 模型摘要
By submitting an article for publication, the authors agree to the transfer of the copyright to the publisher upon acceptance.
原文 ↗出版商官网 ·- 开放获取
Only English-language papers are considered. 模型摘要
Only papers written in English are considered.
原文 ↗出版商官网 ·- 同行评审 Peer Review
Double-blind peer review; referee and author identities are anonymous throughout the process. 模型摘要
We use a double-blind peer-review system where both the referee and author remain anonymous throughout the process. We aim to provide authors with timely and constructive feedback regarding their submitted manuscripts.
原文 ↗出版商官网 ·- 查重 Plagiarism
Plagiarism at any stage may lead to rejection, return for correction, or retraction. 模型摘要
At any stage of peer-review, publication, or post-publication, if plagiarism is detected the manuscript may be rejected, returned to the author for correction, or retracted.
原文 ↗出版商官网 ·- 试验注册 / 报告规范
Clinical trials must be registered in a WHO-approved or other publicly available registry, with the trial number stated in the manuscript. 模型摘要
All clinical trials should be registered in a publicly available registry approved by the WHO or other organizations and the clinical trial number must be clearly stated in the manuscript.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Society of Pharmaceutical Education & Research [SPER]
- ISSN
- 2249-3379
- 官方链接
- 期刊主页 ↗OpenAlex
常见问题
关于 Journal of Advanced Pharmacy Education and Research 的常见问题
Journal of Advanced Pharmacy Education and Research 的投稿格式要求是什么？
据期刊作者指南：摘要：150–250 词；关键词：≥ 4 个；正文篇幅：≤ 7,000 词；参考文献格式：顺序编码制（按引用顺序编号）；首次投稿格式：允许不按期刊格式排版（free format）；投稿信：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Journal of Advanced Pharmacy Education and Research 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Journal of Advanced Pharmacy Education and Research 被 Scopus 收录。期刊官网自述还被 CAB Abstracts 收录，该清单未与各数据库逐一核对。
Journal of Advanced Pharmacy Education and Research 是开放获取期刊吗？版面费多少？
Journal of Advanced Pharmacy Education and Research 为订阅期刊。收取 APC，金额未公布。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。